Dr. Benjamin Besse, Head of Medical Oncology at Institut Gustave Roussy, reviews his path into oncology & describes how strong national programs & a collaborative oncology community conduct translational research together across France. (24:50)
Dr. Reshma Jagsi, radiation oncologist at University of Michigan, discusses her work on gender equity and disparities in medicine along with the challenges in overcoming them with host Dr. Jack West. (25:50)
Dr. Reshma Jagsi, radiation oncologist at University of Michigan, speaks with Dr. Jack West about her parents settling in Texas, her childhood, her move to Harvard to study government, & shaping her career & personal life priorities. (39:18)
Dr. Ben Solomon, thoracic oncologist at the Peter MacCallum Cancer Centre in Melbourne, Australia, recounts unique aspects of cancer care in Australia & his circuitous path from Sri Lanka to Zambia and Colorado before settling in Australia. (25:23)
Host Jack West speaks with Dr. Yuman Fong, surgical oncologist at City of Hope, about a multidisciplinary approach to metastatic cancer that includes local therapies to improve survival & potentially cure selected patients with colon & other cancers. (32:23)
Dr. Yuman Fong, surgical oncologist at City of Hope Cancer Center, recounts how he defined career goals, the experience of raising 3 daughters in NYC with a wife who is a successful lawyer, & his efforts to balance his work with personal commitments. (28:30)
Dr. Tony Mok of the Chinese University of Hong Kong reflects with host Dr. Jack West on his circuitous career path that led him back to Hong Kong after training in Edmonton & Toronto, as well as the exciting career opportunities he has cultivated. (29:09)
Lung cancer advocates Ivy Elkins and Jill Feldman talk with Dr. West about the role of cancer patient advocates working with researchers, attending professional conferences, as well as how different cultures manage a life-threatening cancer diagnosis. (21:23)
Lung cancer advocates Jill Feldman and Ivy Elkins discuss the value in terms of both needed support & information sharing from fellow patients, whether in direct local contact or via online connections, & value of the EGFR Resisters group. (28:27)
